4 Stocks Expected to Play Worst Today (FLT, OCLS, SCTY, INO)

Los Angeles, CA -- (SBWIRE) -- 03/07/2013 -- FleetCor Technologies Inc. (NYSE:FLT) said selling stockholders have agreed to sell 4.5 million shares. The company had about 81.2 million shares outstanding as of Feb. 8. Shares slipped 2.42% to $70.50.

FleetCor Technologies, Inc. is an independent global provider of specialized payment products and services to businesses, commercial fleets, oil companies, petroleum marketers and government entities in countries throughout North America, Latin America and Europe.

How Should Investors React To FLT Now? Find Out Here

Oculus Innovative Sciences Inc. (NASDAQ:OCLS) is already considered a penny stock, but its shares are down a sharp 20.72% at $0.428 to a new 52-week low (prior low $0.50) on news that it is raising capital in a stock and securities sale of 7.5 million shares.

Oculus Innovative Sciences, Inc. is a commercial healthcare company that designs, produces, and markets safe drugs, devices, and nutritional products. The Company's primary focus is on its technology platform called Microcyn Technology.

How Should Investors Trade OCLS Now? Find Out Here

Solarcity Corp. (NASDAQ:SCTY) was supposed to be immune from the solar woes since it is the installer and manager of systems. Unfortunately it posted a loss on lighter-than-expected sales. Shares were down more than 10% last night but the stock is down 13.91% at $16.59 today.

SolarCity Corporation is engaged in the design, installation and sale or lease of solar energy systems to residential and commercial customers, or sale of electricity generated by solar energy systems to customers. The Company’s solar energy products include Solar Energy Systems, and SolarLease and power purchase agreement finance products.

What Should Investors Do With SCTY Now? Find Out Here

Inovio Pharmaceuticals, Inc. (NYSE:INO) is down 23.23%; priced an underwritten offering of 27,377,266 shares of its common stock and warrants to purchase up to 13,688,633 shares of common stock at a combined price to the public of $0.55 per share and related warrant for gross proceeds of $15.1 million. The warrants are exercisable at an exercise price of $.7936 per share and will expire, unless exercised, on the date that is 180 days after the fifth anniversary of the date of issuance.

Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases.

Is INO Showing Any Sign of Buy At The Current Market Price? Find Out Here

DISCLAIMER:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Adviser or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com